1. Home
  2. KFY vs RCUS Comparison

KFY vs RCUS Comparison

Compare KFY & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korn Ferry

KFY

Korn Ferry

HOLD

Current Price

$63.35

Market Cap

3.4B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.59

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFY
RCUS
Founded
1969
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
KFY
RCUS
Price
$63.35
$22.59
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$78.00
$30.30
AVG Volume (30 Days)
489.5K
1.1M
Earning Date
03-11-2026
05-28-2026
Dividend Yield
3.07%
N/A
EPS Growth
42.41
N/A
EPS
2.61
N/A
Revenue
$1,819,519,000.00
$247,000,000.00
Revenue This Year
$5.75
N/A
Revenue Next Year
$4.02
$19.94
P/E Ratio
$24.01
N/A
Revenue Growth
12.20
N/A
52 Week Low
$58.95
$6.79
52 Week High
$78.50
$26.40

Technical Indicators

Market Signals
Indicator
KFY
RCUS
Relative Strength Index (RSI) 48.11 57.16
Support Level $62.46 $20.35
Resistance Level $63.51 $24.16
Average True Range (ATR) 1.77 1.38
MACD 0.23 0.44
Stochastic Oscillator 93.64 65.46

Price Performance

Historical Comparison
KFY
RCUS

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: